Company / Operating Cash Flow
PRECISION BIOSCIENCES INC Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$58.4M
FY2025
5-year range
-$87.4M / -$10.9M
FY2021-FY2025
Trend
+30.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$58M.
Based on SEC 10-K filings.
-$58M in FY2025.
Declined from -$46M to -$58M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 30.5% year-over-year.
- Peak operating cash flow was recorded in FY2022.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$58.4M | +30.5% |
| FY2024 | -$84.1M | -83.8% |
| FY2023 | -$45.8M | -321.6% |
| FY2022 | -$10.9M | +87.6% |
| FY2021 | -$87.4M | -23.1% |
| FY2020 | -$71.0M | -37.3% |
| FY2019 | -$51.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026